Plx Pharma Drug Patent Portfolio

Plx Pharma owns 1 orange book drug protected by 7 US patents Given below is the list of Plx Pharma's drug patents along with their expiration dates.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US10646431 PH dependent carriers for targeted release of pharmaceuticals along the gastrointestinal tract, compositions therefrom, and making and using same 29 Sep, 2032
Active
US10786444 PH dependent carriers for targeted release of pharmaceuticals along the gastrointestinal tract, compositions therefrom, and making and using same 29 Sep, 2032
Active
US9216150 pH dependent carriers for targeted release of pharmaceuticals along the gastrointestinal tract, compositions therefrom, and making and using same 29 Sep, 2032
Active
US9226892 pH dependent carriers for targeted release of pharmaceuticals along the gastrointestinal tract, compositions therefrom, and making and using same 29 Sep, 2032
Active
US8865187 Compositions comprising lecithin oils and NSAIDs for protecting the gastrointestinal tract and providing enhanced therapeutic activity 23 Mar, 2022 Expired
US9101637 Methods of treating inflammation with compositions comprising lecithin oils and NSAIDS for protecting the gastrointestinal tract and providing enhanced therapeutic activity 23 Mar, 2022 Expired
US9351984 Compositions comprising lecithin oils and NSAIDs for protecting the gastrointestinal tract and providing enhanced therapeutic activity 19 Dec, 2021 Expired


Given below is the list of recent legal activities going on the following drug patents of Plx Pharma.

Activity Date Patent Number
Patent litigations
Payment of Maintenance Fee, 4th Yr, Small Entity 14 Mar, 2024 US10786444
Payment of Maintenance Fee, 4th Yr, Small Entity 25 Oct, 2023 US10646431
Expire Patent 18 Sep, 2023 US9101637
Payment of Maintenance Fee, 8th Yr, Small Entity 02 Aug, 2023 US9226892
7.5 yr surcharge - late pmt w/in 6 mo, Small Entity 02 Aug, 2023 US9226892
Payment of Maintenance Fee, 8th Yr, Small Entity 07 Jun, 2023 US9216150
Maintenance Fee Reminder Mailed 03 Apr, 2023 US9101637
Expire Patent 28 Nov, 2022 US8865187
Maintenance Fee Reminder Mailed 13 Jun, 2022 US8865187
Recordation of Patent Grant Mailed 29 Sep, 2020 US10786444
Patent Issue Date Used in PTA Calculation 29 Sep, 2020 US10786444
Email Notification 15 Sep, 2020 US10786444
Issue Notification Mailed 09 Sep, 2020 US10786444
Application Is Considered Ready for Issue 17 Aug, 2020 US10786444
Dispatch to FDC 17 Aug, 2020 US10786444


Plx Pharma's Drug Patent Litigations

Plx Pharma's drugs have been subject to various legal proceedings, including patent litigations. The earliest legal proceeding was initiated on Jan 02, 2014, against patent number US8865187. The petitioner , challenged the validity of this patent, with Lenard M. Lichtenberger as the respondent. Click below to track the latest information on how companies are challenging Plx Pharma's patents.

Patent Proceeding Filing Date Status Respondent Petitioner
Patent litigations
US8865187 January, 2014 Decision
(17 Jun, 2014)
Lenard M. Lichtenberger


Plx Pharma's Family Patents

Plx Pharma drugs have patent protection in a total of 18 countries. It's US patent count contributes only to 37.3% of its total global patent coverage. 8 countries have all of their patents expired or invalidated which has opened up potential generic launch opportunities in these countries. Click below to unlock the full patent family tree.

Family Patents



Plx Pharma Drug List

Given below is the complete list of Plx Pharma's drugs and the patents protecting them.


1. Vazalore

Vazalore is protected by 7 patents, out of which 3 have expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US10646431 PH dependent carriers for targeted release of pharmaceuticals along the gastrointestinal tract, compositions therefrom, and making and using same 29 Sep, 2032
(7 years from now)
Active
US10786444 PH dependent carriers for targeted release of pharmaceuticals along the gastrointestinal tract, compositions therefrom, and making and using same 29 Sep, 2032
(7 years from now)
Active
US9216150 pH dependent carriers for targeted release of pharmaceuticals along the gastrointestinal tract, compositions therefrom, and making and using same 29 Sep, 2032
(7 years from now)
Active
US9226892 pH dependent carriers for targeted release of pharmaceuticals along the gastrointestinal tract, compositions therefrom, and making and using same 29 Sep, 2032
(7 years from now)
Active
US8865187 Compositions comprising lecithin oils and NSAIDs for protecting the gastrointestinal tract and providing enhanced therapeutic activity 23 Mar, 2022
(2 years ago)
Expired
US9101637 Methods of treating inflammation with compositions comprising lecithin oils and NSAIDS for protecting the gastrointestinal tract and providing enhanced therapeutic activity 23 Mar, 2022
(2 years ago)
Expired
US9351984 Compositions comprising lecithin oils and NSAIDs for protecting the gastrointestinal tract and providing enhanced therapeutic activity 19 Dec, 2021
(2 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Vazalore's drug page


Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List